Adjustable flow glaucoma shunts and methods for making and using same

ABSTRACT

Adjustable flow glaucoma shunts are disclosed herein. In one embodiment, for example, an adjustable flow shunt can include an outflow drainage tube having a proximal inflow region and a distal outflow region. The proximal inflow region can include aperture(s) defining a fluid inlet area positioned to allow fluid to flow therethrough. The shunt further comprises an inflow control assembly at the proximal inflow region. The inflow control assembly can include a control element configured to slidably engage the proximal inflow region and a spring element. The spring element is configured to be activated by non-invasive energy and, upon activation, slidably move the control element along the proximal inflow region such that (a) the one or more apertures are accessible and have a first fluid flow cross-section or (b) the one or more apertures are at least partially covered by the control element and have a second, different fluid-flow cross-section.

CROSS-REFERENCE TO RELATED APPLICATION(S)

This application is a continuation of U.S. patent application Ser. No.16/840,108, filed Apr. 3, 2020, which is a continuation of U.S. patentapplication Ser. No. 16/632,008, filed Jan. 17, 2020, now issued as U.S.Pat. No. 11,058,581, which is a 35 U.S.C. § 371 U.S. National Phaseapplication of International Patent Application No. PCT/US2018/043158,filed Jul. 20, 2018, which claims priority to U.S. Provisional PatentApplication No. 62/643,125, filed Mar. 14, 2018, Provisional PatentApplication No. 62/626,615, filed Feb. 5, 2018, and Provisional PatentApplication No. 62/535,125, filed Jul. 20, 2017, the contents of whichare all incorporated herein by reference in their entireties.

TECHNICAL FIELD

The present technology relates to adjustable flow glaucoma shunts andmethods for making and using such devices.

BACKGROUND

Glaucoma, ocular hypertension, is a disease associated with an increasein pressure within the eye resultant from an increase in production ofaqueous humor (aqueous) within the eye and/or a decrease in the rate ofoutflow of aqueous from within the eye into the blood stream. Aqueous isproduced in the ciliary body at the boundary of the posterior andanterior chambers of the eye. It flows into the anterior chamber andeventually into the capillary bed in the sclera of the eye. Glaucomatypically results from a failure in mechanisms that transport aqueousout of the eye and into the blood stream.

Normal aqueous production, for example, is around 2.5 uL/min, and if itis assumed the lowest pressure that can exist in the capillary bed intowhich the aqueous drains is 0 torr, then maximum outflow resistance in anormal eye at the maximum of normal pressure is expected to beapproximately 9 torr/(uL/min). Normal pressure within the eye rangesbetween 12 torr and 22 torr. As noted above, glaucoma is usuallyassociated with high pressure inside the eye that can damage eye tissuesand result in vision loss. The condition where pressures aresignificantly below this range is called hypotany or ocular hypotension.In some patients, hypotany can be just as damaging (if not more) thanglaucoma.

The early stages of glaucoma are typically treated with drugs. When drugtreatments no longer suffice, however, surgical approaches are used.Surgical or minimally invasive approaches primarily attempt to lower theoutflow resistance of aqueous from the anterior chamber to the bloodstream either by the creation of alternative fluid paths or theaugmentation of the natural paths for aqueous outflow.

Devices used to lower outflow resistance are generally referred to as“glaucoma shunts” or “shunts.” FIGS. 1A-1C, for example, illustrateseveral different traditional glaucoma plate shunts 100 (identifiedindividually as 100 a-c) configured to provide constant resistance toflow. The shunt 100 a of FIG. 1A, for example, includes a plate 103 a, aplurality of outflow ports 102 a, one or more inflow ports 101, andtie-downs or engagement features 104 a. The shunts 100 b and 100 c shownin FIGS. 1B and 1C, respectively, include several features similar tothe features of shunt 100 a. For example, these shunts 100 b-c includeplates 103 b-c, outflow ports 102 b-c, and tie-downs or engagementfeatures 104 b-c. The shunts 100 b-c, however, include an inflow tube105 instead of the inflow ports 101 of the shunt 100 a.

FIGS. 2A and 2B illustrate a human eye E and suitable location(s) inwhich shunts 100 a-c may be implanted within the eye. More specifically,FIG. 2A is a simplified front view of the eye E, and FIG. 2B is anisometric view of the eye capsule of FIG. 2A. Referring first to FIG.2A, the eye E includes a number of muscles to control its movement,including a superior rectus SR, inferior rectus IR, lateral rectus LR,medial rectus MR, superior oblique SO, and inferior oblique IO. The eyeE also includes an iris, pupil, and limbus.

Referring to FIGS. 2A and 2B together, shunt 100 c is positioned suchthat inflow tube 105 is positioned in an anterior chamber of the eye,and outflow ports 102 c are positioned at a different location withinthe eye. Depending upon the design of the device, the outflow ports 102c may be place in a number of different suitable outflow locations(e.g., between the choroid and the sclera, between the conjunctiva andthe sclera). For purposes of illustration, only shunt 100 c is shownimplanted in the eye E. It will be appreciated, however, that shunts 100a-b may be similarly implanted within the eye E.

Outflow resistance typically depends on the outflow location.Additionally, outflow resistance changes over time as the outflowlocation goes through its healing process after surgical implantation ofthe device. Because the outflow resistance changes over time, in manyprocedures the shunt 100 a-c is modified at implantation to temporarilyincrease its outflow resistance. After a period of time deemedsufficient to allow for healing of the tissues and stabilization of theoutflow resistance, the modification to the shunt 100 a-c is reversed,thereby decreasing the outflow resistance. Such modifications can beinvasive, time-consuming, and expensive for patients. If such aprocedure is not followed, however, the likelihood of creating hypotanyand its resultant problems is high.

BRIEF DESCRIPTION OF THE DRAWINGS

Many aspects of the present technology can be better understood withreference to the following drawings. The components in the drawings arenot necessarily drawn to scale. Instead, emphasis is placed onillustrating clearly the principles of the present technology.Furthermore, components can be shown as transparent in certain views forclarity of illustration only and not to indicate that the component isnecessarily transparent. Components may also be shown schematically.

FIGS. 1A-1C illustrate traditional glaucoma plate shunts configured toprovide constant resistance to flow.

FIG. 2A is simplified front view of an eye E with an implanted shunt,and FIG. 2B is an isometric view of the eye capsule of FIG. 2A.

FIGS. 3A and 3B illustrate an adjustable flow glaucoma shunt configuredin accordance with an embodiment of the present technology.

FIG. 3C is a partially schematic illustration of an eye capsule of ahuman patient showing the adjustable flow glaucoma shunt of FIGS. 3A and3B implanted within the eye capsule.

FIGS. 3D and 3E illustrate inflow regions configured in accordance withadditional embodiments of the present technology.

FIGS. 4A-4C illustrate an adjustable flow glaucoma shunt configured inaccordance with another embodiment of the present technology.

FIGS. 5A-6B illustrate inflow control assemblies configured inaccordance with embodiments of the present technology.

FIGS. 7A-7E illustrate a variable flow shunt configured in accordancewith an embodiment of the present technology.

FIGS. 8A-9B illustrate additional embodiments of variable flow glaucomashunt devices configured in accordance with the present technology.

FIG. 10 illustrates a variable flow shunt device including an actuatablemember at an outflow end of the device in accordance with an embodimentof the present technology.

FIGS. 11A-11C illustrate a ribbon or wire composed of shape memorymaterial and configured in accordance with an embodiment of the presenttechnology.

FIGS. 12A and 12B illustrate a fluid control element including variablefluid resistors composed of shape memory materials in accordance with anembodiment of the present technology.

FIGS. 13A and 13B are partially schematic, cross-sectional views of avariable fluid resistor comprising a dual lumen elastomeric tubeconfigured in accordance with an embodiment of the present technology.

FIGS. 13C-13F illustrate additional embodiments of variable fluidresistor devices configured in accordance with the present technology.

FIGS. 14A and 14B illustrate a fluid control element including variablefluid resistors composed of shape memory materials in accordance withadditional embodiments of the present technology.

FIGS. 15A-15C illustrate an adjustable flow glaucoma shunt configured inaccordance with another embodiment of the present technology.

FIGS. 16A-16E illustrate an adjustable flow glaucoma shunt configured inaccordance with still another embodiment of the present technology.

DETAILED DESCRIPTION

The present technology is directed to adjustable flow glaucoma shuntsand methods for making and using such devices. In many of theembodiments disclosed herein, the adjustable flow glaucoma shuntscomprise an adjustable fluid resistor (“resistor” within the context ofthis document refers to a fluid resistor), actuator, and/or actuationmechanism. Additionally, in certain embodiments, the shunts may alsoinclude an adjustable opening pressure control mechanism. Thesemechanisms can be selectively adjusted or modulated to increase ordecrease the outflow resistance and/or opening pressure of the shunt inresponse to changes in any (or any combination of) intraocular pressure(IOP), aqueous production rate, native aqueous outflow resistance,and/or native aqueous outflow rate.

In one embodiment, for example, an adjustable flow shunt for treatingglaucoma in a human patient comprises an elongated outflow drainage tubehaving a proximal inflow region and a distal outflow region. Theproximal inflow region can include one or more apertures defining afluid inlet area positioned to allow fluid to flow therethrough and intothe outflow drainage tube. The adjustable flow shunt further comprisesan inflow control assembly at the proximal inflow region. The inflowcontrol assembly can include a control element sized and shaped toslidably engage the proximal inflow region and a spring element operablycoupled between the control element and an anchor element engaged withthe proximal inflow region. The spring element is configured to beactivated by a non-invasive energy and, upon activation, slidably movethe control element along the proximal inflow region such that (a) theone or more apertures are accessible and have a first fluid flowcross-section or (b) the one or more apertures are at least partiallycovered by the control element and have a second fluid-flowcross-section less than the first fluid flow cross-section.

In another embodiment of the present technology, an adjustable flowshunt for treatment of glaucoma may comprise an elongated outflow tubehaving (a) a proximal inflow portion configured for placement within ananterior chamber in a region outside of an optical field of view of aneye of the patient, and (b) a distal outflow portion at a differentlocation of the eye. The adjustable flow shunt also includes an actuatorpositioned along the outflow tube between the inflow portion and theoutflow portion. The actuator is transformable between an open positionthat allows fluid to flow through the outflow tube and resistancepositions that partially obstruct fluid flow through the outflow tube.During operation, the actuator is movable between positions in responseto non-invasive energy.

An adjustable flow shunt assembly configured in accordance with stillanother embodiment of the present technology can include an elongateddrainage tube having a proximal portion and a distal portion. Theproximal portion includes an inflow port configured to be in fluidcommunication with a fluid chamber in an eye of the patient. Theadjustable flow shunt can also include a variable resistor assemblyconfigured to selectively control flow of fluid into the inflow port.The variable resistor assembly in this embodiment comprises a baseportion and an aperture plate carried by the base portion. The apertureplate comprises a plurality of first apertures extending therethrough.The variable resistor assembly also comprises a standoff plate carriedby and extending away from the aperture plate. The standoff platecomprises a plurality of second apertures extending therethrough, withthe second apertures aligned with corresponding first apertures of theaperture plate. The variable resistor assembly further comprises amembrane disposed on and carried by the standoff plate. The membrane ispositioned to sealably cover an open end of each of the secondapertures. During operation of the shunt assembly, a portion of themembrane over one or more second apertures of the standoff plate isconfigured to be selectively targeted and removed via non-invasiveenergy, thereby creating a fluid path from the site of fluid in thepatient through the accessible open ends of the targeted secondapertures, the corresponding first apertures, and into the drainagetube.

Specific details of various embodiments of the present technology aredescribed below with reference to FIGS. 3A-16E. Although many of theembodiments are described below with respect to adjustable flow glaucomashunts and associated methods, other embodiments are within the scope ofthe present technology. Additionally, other embodiments of the presenttechnology can have different configurations, components, and/orprocedures than those described herein. For instance, shunts configuredin accordance with the present technology may include additionalelements and features beyond those described herein, or otherembodiments may not include several of the elements and features shownand described herein.

For ease of reference. throughout this disclosure identical referencenumbers are used to identify similar or analogous components orfeatures, but the use of the same reference number does not imply thatthe parts should be construed to be identical. Indeed, in many examplesdescribed herein, the identically numbered parts are distinct instructure and/or function.

Selected Embodiments of Variable Flow Glaucoma Shunts

FIGS. 3A-16E illustrate a number of different embodiments for variableflow glaucoma shunt devices, along with particular components andfeatures associated with such devices. FIG. 3A, for example, illustratesa variable flow glaucoma shunt 300 (“shunt 300”) configured inaccordance with an embodiment of the present technology. The shunt 300includes an inflow control assembly 338 and an outflow drainage tube oroutflow assembly 327. The inflow control assembly 338 of the shunt 300is configured for placement within an anterior chamber in a regionoutside of the optical field of view of the eye, but within a regionvisible through the cornea (as described below with reference to FIG.3C). The outflow drainage tube 327 comprises tubing (e.g., a fine borelength of thin walled tubing) sized and shaped to span the regionbetween the anterior chamber and a desired outflow location. Asdescribed in greater detail below, the inflow control assembly 338comprises a control mechanism configured to act as a variable resistorduring operation.

FIG. 3B is a partially exploded view of the shunt 300 with a portion ofthe inflow control assembly 338 removed from the outflow drainage tube327 for purposes of illustration. As best seen in FIG. 3B, a proximalend 360 of the outflow drainage tube 327 comprises a proximal inflowregion defined by a core element or core feature 342 extendingtherefrom. The core element 342 may be composed of a relatively stiffmaterial or a combination of stiff materials including, but not limitedto, polyether ether ketone (PEEK), acrylic, polycarbonate, metal,ceramic, quartz, and/or sapphire. The portion of the outflow drainagetube 327 not comprised in the core element 342 may be composed of arelatively flexible material (e.g., silicone, urethane, or anothersuitable material). The core element 342 includes one or more aperturesor openings 341 (only one is shown in the illustrated embodiment) thatdefine a fluid inlet area 362. The fluid inlet area 362 is in fluidcommunication with a lumen of the outflow drainage tube 327. In otherembodiments, the aperture(s) 341 may have a different arrangement and/orthere may be a different number of apertures 341. For example, inanother embodiment the aperture 341 may extend helically about the coreelement 342. The aperture(s) 341 are positioned to allow fluid to flowtherethrough during operation of the shunt 300.

Referring to FIGS. 3A and 3B together, for example, the inflow controlassembly 338 in the illustrated embodiment includes a control element339 configured to be positioned on or around an external surface of thecore element 342 (as shown by the arrow in FIG. 3B). During operation,the control element 339 may be adjusted to cover more or less of thefluid inlet area 362. For example, in some embodiments, the controlelement 339 may be adjusted to increase or decrease the length of afluid path between an edge of the control section 339 and theaperture(s) 341 (FIG. 3B). In some embodiments, a hydrogel coating maybe applied to an inside surface of the control element 339 to furtherenhance the ability of the control element 339 to slide relative to thecore element 342 and enhance sealing of the components during operation.In additional embodiments, the hydrogel coating may also be applied tothe core element 342 (in addition to, or in lieu of, application of thecoating on the control element 339). Further details regardingadjusting/manipulating the control element 339 are described below.

The inflow control assembly 338 in the illustrated embodiment can alsoinclude an adjustable spring element (shown as first and second springelements 340 and 340′) arranged on opposite sides of the control element339. Each spring element 340 and 340′ may further comprise acorresponding anchor element 310.

In the embodiment illustrated in FIGS. 3A and 3B, the control element339 is composed of a single material. For example, the control element339 may be fabricated from materials such as (but not limited to)ceramics, alumina oxide, silica oxide, sapphire, and/or quartz. Suchmaterials, for example, may be ground to very high tolerances/precisedimensions. In other embodiments, however, the control element 339 mayhave different portions/regions composed of different materials. Thefirst and second spring elements 340 and 340′ may be composed of a shapememory material (e.g., nitinol or another suitable shape memorymaterial) capable of activation via non-invasive energy, such as light(and or heat). The anchor elements 310 may be fabricated from similarmaterial(s) or other suitable materials.

In operation, first and second spring elements 340 and 340′ areconfigured to be selectivity activated by non-invasive energy and, uponactivation, slidably move the control element 339 along the proximalinflow region in a first direction or a second direction, respectively,such that (a) the aperture(s) 341 have a first fluid flow cross-section(e.g., completely open and accessible), or (b) the aperture(s) are atleast partially covered by the control element 339 and have a secondfluid-flow cross-section less than the first fluid flow cross-section(e.g., partially open/accessible). Further, in some instances thecontrol element 339 may be slidably adjusted such that the aperture(s)341 are fully covered and inaccessible. One feature of the arrangementshown in FIGS. 3A and 3B is that the inflow control assembly 338 can beselectively adjusted after placement within the eye (e.g., vianon-invasive energy) to provide a variety of different outflowresistance levels by incrementally adjusting the control element 339relative to the aperture(s) 441.

FIG. 3C is a partially schematic illustration of an eye capsule of ahuman patient showing the adjustable flow glaucoma shunt 300 of FIGS. 3Aand 3B implanted within the eye capsule. In particular, a typicalsurgery for implantation of the shunt 100 in the eye capsule comprisesthe following: (a) a portion of conjunctiva is peeled back; (b) aportion of sclera is removed to create a pocket where the plate is to beplaced; (c) the inflow control assembly 338 is routed into the anteriorchamber of the eye capsule; (d) the outflow drainage tube 327 isextended through the tissue and into a desired pocket; and (e) theoutflow drainage tube 327 and any other portions of the shunt 300 nototherwise buried in the other tissues are covered with conjunctiva. Inthe embodiment illustrated in FIG. 3C, for example, the shunt 300 isconfigured for placement traversing a region in the anterior chamber toa region in a suprachoroidal location of the eye. In other embodiments,however, the shunt 300 may be adapted for placement within differentportions of the eye. In one embodiment, for example, shunts configuredin accordance with the present technology may be positioned at asubconjunctival region within the eye.

FIGS. 3D and 3E illustrate core elements configured in accordance withdifferent embodiments of the present technology. Referring first to FIG.3D, for example, core element 342 comprises a plurality of apertures oropenings 341′ extending therethrough and defining, at least in part, afluid path in communication with a lumen of the corresponding outflowdrainage tube 327. The apertures 341′ in the illustrated embodiment havea different arrangement/configuration than the aperture 341 describedabove with reference to FIGS. 3A and 3B. It will be appreciated thatwhile six apertures 341′ are shown in FIG. 3D, the core element 342 mayinclude a different number of apertures 341′ in other embodiments.Moreover, the apertures 341′ may have a different arrangement relativeto each other. FIG. 3E illustrates yet another embodiment of coreelement 342 having apertures 341″ configured in accordance with stillyet another arrangement of the present technology. In this embodiment,the apertures 341″ comprise a plurality of elongated slots arrangedabout the core element 342. In other embodiments, the apertures341′/341″ may have a variety of other suitable shapes/sizes.

FIGS. 4A-4C illustrate a variable flow glaucoma shunt 400 (“shunt 400”)configured in accordance with yet another embodiment of the presenttechnology. The shunt 400 includes an inflow control assembly 438 and anoutflow drainage tube or outflow assembly 427. The inflow controlassembly 438 includes several features similar to the inflow controlassembly 338 of the shunt 300 described above with reference to FIGS. 3Aand 3B. For example, inflow control assembly 438 includes a first orproximal spring element 440′ and a second or distal spring element 440arranged adjacent each other. The inflow control assembly 438 furtherincludes a core element or feature 442 coupled to an inner portion ofthe inflow control assembly at anchor point 442′ (as best seen in FIGS.4B and 4C) between the spring elements 440 and 440′. A fixation spine451 extends between and is operably coupled to the spring elements 440and 440′. Although only one fixation spine 451 is shown in theillustrated embodiment, in other embodiments the shunt 400 may includeone or more additional fixation spines. In the illustrated embodiment,the fixation spine 451 and first and second spring elements 440 and 440′are all integrally formed from the same tube using a laser cuttingprocess. In other embodiments, however, the spring elements 440 and 440′and/or fixation spine 451 may be separate, discrete components formedfrom different materials.

In operation, the shunt 400 is configured to operate in an analogousfashion to the shunt 300 described above with respect to FIGS. 3A-3C. Inparticular, the first and second spring elements 440 and 440′ areconfigured to be selectivity activated by non-invasive energy and, uponactivation, slidably move the core element 442 to change the length of aflow path through openings or slits 460 of the inflow control assembly438. Referring to FIG. 4B, for example, when the distal spring 440 isexpanded/actuated, the core element 442 moves proximally and the lengthof the core portion 442 inside an uncut portion of the shunt 400 (andthe corresponding flow F through openings 460 and along flow path FP inthe inflow control assembly 438) is at a minimum.

Referring to FIG. 4C, however, when the distal spring 440 is compressedand the proximal spring 440′ is expanded/actuated, the length of thecore portion 442 inside the uncut portion (and the corresponding flow Falong flow path FP) is maximized. The disclosed arrangement is expectedto provide an effective and predictable way to incrementallyincrease/decrease flow resistance in a linear fashion via the shunt 400.In other embodiments, rather than the incremental adjustments in flowrate provided by the shunt 400 shown in FIGS. 4A-4C, the shunt 400 maybe configured to provide a binary on/off arrangement via selectiveactuation of the first and second spring elements 440 and 440′. Further,in some embodiments, the width and/or shape of the openings/slits 460can be modified to allow for further control of the flow resistance ofthe shunt 400. In yet another embodiment the core pin may be affixed tothe proximal end of spring element 440′ and not extend into a flow path.In such an embodiment, the flow path is altered by expanding orcompressing the space between the elements of the spring 440 and 440′.In other embodiments, the shape of the pin and or the inner lumen can bemodified to change allow for a nonlinear control of flow as a functionof core travel.

FIGS. 5A-6B illustrate inflow control assemblies configured inaccordance with further embodiments of the present technology. Referringfirst to FIGS. 5A and 5B, for example, inflow control assembly 538 ispositioned on or around an external surface of core element 542 at theinflow or inlet region of the drainage tube 527. Inflow control assembly538 comprises control element 539 and spring elements 540 fixed theretoand extending in a proximal direction toward the drainage tube 527. Theinflow control assembly 538 further includes an anchor element 510operably coupled to the spring elements 540 at a proximal region of theinflow control assembly 538. FIG. 5A illustrates the inflow controlassembly 538 in a low or minimum flow configuration in which controlelement 539 is positioned entirely over or approximately entirely overapertures 541 (FIG. 5B) in the core element 542. FIG. 5B illustrates theinflow control assembly 538 in a maximum flow configuration in which thespring elements 540 have been actuated. In some embodiments, forexample, the spring element 540 may be heated via non-invasive energy(e.g., laser energy), thereby causing the spring elements 540 to bowoutwardly and slidably move control element 539 in a proximal directionsuch that apertures 541 are exposed and fluid can flow therethrough intodrainage tube 527.

FIGS. 6A and 6B illustrate another embodiment of an inflow controlassembly 638 configured in accordance with the present technology. Inthis embodiment, the inflow control assembly 638 includes a controlelement 639 and first and second spring elements 640 and 640′ fixedthereto and extending in a proximal direction toward the drainage tube627. The first and second spring elements 640 and 640′ have a differentconfiguration than spring elements 540 and 540′ described above withreference to FIGS. 5A and 5B. Further, each spring element 640 and 640′is operably coupled to a corresponding anchor element 610 and 610′.Because the individual spring elements 640 and 640′ have their ownanchor elements 610 and 610′, respectively, the spring elements 640 and640′ can be independently set in an initial configuration andindependently controlled during operation. As shown in FIG. 6B, forexample, the individual spring elements 640 and 640′ can be actuated(e.g., via heat), thereby causing the spring elements 640 and 640′ tocoil more tightly and slidably move control element 639 in a proximaldirection along core element 642 and create an open fluid path (to alumen of drainage tube 627) via exposed apertures 641.

In the embodiments shown in in FIGS. 3A-6B, the inflow ends of thevarious illustrated shunts are sealed. Such shunts may be delivered viaa needle (not shown) traversing a desired flow path (as described abovewith reference to FIG. 3C). In other embodiments, however, the inflowend of a shunt may be initially open (such that the shunt can bedelivered over a guide wire) and then sealed after delivery andplacement.

Additional Embodiments of Adjustable Flow Glaucoma Shunts

A collection of additional embodiments of adjustable flow and/oradjustable pressure regulated glaucoma shunts comprising plates aredescribed below with reference to FIGS. 7A-16E. Such shunts may beimplanted as described above and illustrated in FIG. 3C, or the shunt(s)may be implanted using other suitable techniques and in other suitablelocations within the eye. In some of these embodiments, traditionaloutflow ports are augmented with additional tubes to distribute theaqueous over larger regions of tissue. Outflow tube(s) are covered by atleast the conjunctiva. Many of the embodiments of the present technologyadditionally comprise an adjustable fluid resistor, some of which mayadditionally comprise an adjustable opening pressure control mechanism.These mechanisms can be adjusted to increase or decrease the outflowresistance and/or opening pressure of the shunt in response to changesin the following: IOP, aqueous production rate, native aqueous outflowresistance, native aqueous outflow rate, and combinations thereof.

FIGS. 7A-7E illustrate another embodiment of a variable flow shunt 700configured in accordance with the present technology. FIG. 7A, forexample, is a schematic top view of the shunt 700, which is configuredfor minimally invasive placement (like the shunts described above withreference to FIGS. 3A-6B). The shunt 700 includes an elongated drainagetube 702 having a proximal portion with an inflow port 701 and a distalportion opposite the proximal portion. The shunt 700 differs from theshunts describe above in that fluid resistance of the shunt 700 isselectively controlled by modifying the number of apertures that allowfluid to flow through the inflow port 701. In some embodiments, forexample, the shunt 700 can be configured to allow only for sequentialdecreases in outflow resistance. In other embodiments, however, theshunt 700 may be configured to selectively allow for both finitedecreases and increases in outflow resistance. Further details regardingthe shunt 700 and its operation are described below.

FIG. 7B is an enlarged, partially schematic cross-sectional view of theshunt 700 taken along line B-B of FIG. 7A, and FIG. 7C is an enlargedview of the region C identified in FIG. 7B. Referring to FIGS. 7B and 7Ctogether, the inflow port 701 of the shunt 700 further comprises avariable resistor assembly 720 configured to selectively control flow offluid into the inflow port (and the outflow port 702). The variableresistor assembly 720 comprises a membrane 745 disposed on and carriedby a standoff plate 746. The standoff plate 746 is operably coupled toand extends from aperture plate 747. The aperture plate 747 is carriedby a base portion or housing 748 of the shunt 700.

The aperture plate 747 comprises a plurality of first apertures or firstopenings 760 extending therethrough. The first apertures 760 have afirst cross-sectional dimension D₁ (not shown). The first apertures 760can be precisely formed so that each opening is identical or nearlyidentical and all of the first apertures 760 are a predetermined size.The standoff plate 746 comprises a plurality of second apertures orsecond openings 741 extending therethrough. The second apertures 741have a second cross-sectional dimension D₂ larger than the firstcross-sectional dimension D₁. As will be described in greater detailbelow, the second apertures 741 do not need to be as precisely formed asthe first apertures 760. As shown in FIG. 7C, the membrane 745completely covers one end (an upper or first end) of each of the secondapertures 741. The opposite end of each second aperture 741 (a second orlower end) is aligned with a corresponding first aperture or firstopening 760 extending through the aperture plate 747.

FIG. 7D is a top view of the variable resistor assembly 720. As bestseen in FIG. 7D, the variable resistor assembly 720 further comprises aplurality of target indicia or markers 713 (“targets 713”). Theindividual targets 713 correspond to and are aligned with each firstaperture 741 (FIG. 7B). Referring next to FIG. 7E, after the shunt 700is implanted within a patient and it is desired to reduce the fluidresistance of the shunt 700, non-invasive energy (e.g., a surgicallaser) can directed at a selected target 713 on membrane 745. Inembodiments using laser energy, for example, the laser can be activatedor fired to selectively ablate the targeted material of the membrane745, thereby removing such membrane material and exposing the open endof the corresponding second aperture 741. Without the membrane blockingthe targeted second aperture 741, fluid can flow therethrough (as shownby the arrow F), and subsequently through the corresponding firstaperture 760 and into the outflow drainage tube 702. If a furtherreduction in fluid resistance is desired, one or more additional targets713 on membrane 745 may be ablated to expose additional second apertures741 and allow additional fluid to flow therethrough to outflow drainagetube 702.

In the illustrated embodiment, outflow resistance can only be lowered asthere is no means of sealing the second apertures 741 of the implantedshunt 700 once the corresponding targeted portions of the membrane 745are removed to open the second aperture(s) 741 to aqueous flow. In otherembodiments, however, there may be techniques to later impede or stopfluid flow by blocking one or more open second apertures 741. Forexample, referring to FIGS. 7B and 7C, in some embodiments the membrane745 and standoff plate 746 may be composed, at least in part, from ahydrophobic material (e.g., a low melting point wax) adapted to bemelted by the surgical laser (not shown) at temperatures that will notcause particular harm to the aqueous. In such embodiments, a relativelysmall, fine beam from the laser source can be used to melt the waxmaterial of the target membrane 754 and open the corresponding secondaperture 741. At a later point in time, if it is desired to slow orlimit flow of aqueous, a larger beam from the laser source can be usedto melt the wax material of the standoff plate 746, thereby causing thematerial to “puddle” or accumulate over the corresponding secondaperture 760 within the previously opened second aperture 741 and closeor block fluid flow through the first aperture 760.

In the embodiment illustrated in FIGS. 7A-7E, the components of thevariable resistor assembly 720 are separate, discrete components thatare operably coupled together before implantation of the shunt 700. Thecomponents may be composed of similar materials, or one or moredifferent materials. In other embodiments, however, the membrane 745 andstandoff plate 746 may be fabricated as a single unitary componentcomposed of the same material, such as the example described above inwhich the membrane 745 and standoff plate 746 comprise a unitarycomponent composed of a hydrophobic material. In other embodiments,however, the integral membrane 745/standoff plate 746 may be composed ofother suitable materials. In still other embodiments, the standoff plate746 and aperture plate 747 may be fabricated of a single unitarycomponent composed of the same material with the first and secondapertures 741 and 760 formed therein. In yet additional embodiments, theaperture plate 747 may be integrally formed with the base portion 748 ofthe shunt 700.

FIGS. 8A-9B illustrate additional embodiments of variable flow glaucomashunt devices configured in accordance with the present technology. Inthese embodiments, the shunts are configured to be delivered to a targetlocation within an eye capsule of the patient via a guidewire, and thentransformed between a delivery configuration and a deployedconfiguration upon removal of the guidewire. FIG. 8A, for example,illustrates shunt 800 in a delivery configuration on guidewire W. Theshunt 800 includes an inflow control assembly 838 and an outflow tube oroutflow assembly 827. The inflow control assembly 838 can includeseveral features generally similar to the shunts described above withreference to FIGS. 3A-6B. For example, the shunt 800 includes a controlelement 839 positioned over one or more apertures or openings 841 (shownin broken lines) extending through a body portion 848 of the inflowcontrol assembly 838. The aperture(s) 841, when at least partiallyexposed, are configured to allow aqueous to flow therethrough and intothe outflow tube 827. The shunt 800 also comprises a pair of adjustablespring elements 840 and 840′ arranged on opposite sides of the controlelement 839. The spring elements 840 and 840′ are coupled between thebody portion 848 and the control element 839. In some embodiments, thespring elements 840 and 840′ are composed of a shape memory material(e.g., nitinol) and adapted to expand/contract when heat is applied. Forexample, applying heat to the first spring element 840 can induce thisspring element to coil more tightly, thereby moving the control element839 toward the first spring element 840 and stretching or expanding thesecond spring element 840′. Moving the control element 839 also at leastpartially exposes the aperture(s) 841 to allow aqueous to flowtherethrough similar to the techniques described above with reference toFIGS. 3A-6B.

In the illustrated embodiment, the inflow control assembly 838 iscomposed of a first material having a first rigidity and the outflowtube 827 is composed of a second material having a second rigidity lessthan the first rigidity. Referring to FIGS. 8A and 8B together, theshunt 800 may be preshaped prior to implantation such that the shunt 800includes one or more bends along its length. In the illustratedembodiment, for example, the shunt 800 comprises a generally “L” shapedarrangement and includes a bend or elbow 854 at or near a distal regionof the outflow tube 827.

When the shunt 800 is positioned on guidewire W for delivery, the shunt800 assumes a generally linear, straight delivery configuration. Asshown in FIG. 8B, however, when the guidewire W is removed, the shunt800 transforms between its delivery configuration and anexpanded/deployed configuration in which the shunt 800 assumes itspredetermined “L” shaped arrangement including elbow 865. Thisconfiguration is expected to allow for rapid and reliable delivery ofthe shunt 800 via guidewire W, and enable precise placement of theinflow control assembly 838 within the eye capsule of the patient oncethe guidewire is removed and the shunt 800 assumes is predeterminedshape.

FIGS. 9A and 9B illustrate a shunt 900 configured in accordance withstill another embodiment of the present technology. The shunt 900includes a number of features generally similar to the features of shunt800. The shunt 900 differs from shunt 800 in that the shunt 900 is notcomposed of different materials having different rigidities. Rather, theshunt 900 comprises an inflow portion or region 938 and an outflowportion or outflow tube 927 composed of a single material (e.g., a shapememory material such as nitinol). The shunt 900, like shunt 800described above, also includes a preset, generally “L” shapedarrangement and includes a bend or elbow 954. In this embodiment,however, removing the guidewire W does not transform the shunt 900between its delivery configuration (FIG. 9A) and its deployed/expandedconfiguration (FIG. 9B). Instead, as best seen in FIG. 9B, onceguidewire W is removed and the shunt 900 is at a desired location withinthe patient, a laser source (e.g., an ophthalmic laser—not shown) can beused to direct a laser beam to selectively heat a portion of the shunt900 and induce the shunt 900 to bend about elbow 954 and return to itspreset shape (the generally “L” shaped arrangement).

FIG. 10 illustrates a variable flow shunt device 1000 configured inaccordance with yet another embodiment of the present technology. Theshunt 1000 comprises an inflow assembly 1001 and an outflow drainagetube 1027 with an outflow port 1002. The shunt 1000 further comprises anactuatable member 1049 at the outflow end of the outflow port 1002(opposite the inflow assembly 1001). The actuatable member 1049comprises one or more tissue disruption members 1050 (e.g., barbs orother suitable types of devices) to disrupt/disturb tissue at orproximate the outflow end of the outflow port 1001 after the shunt 1000is implanted within the patient. In one embodiment, the barbs 1050 ofthe actuatable member 1049 can be moved and actuated by an operator viaan externally applied magnetic field to disrupt target tissue adjacentthe outflow end of the shunt 1000. In other embodiments, however, thebarbs 1050 may be moved/actuated using other suitable techniques, suchas thermally induced shape changes. Further, it will be appreciated thata different number of barbs 1050 may be used and/or the barbs 1050 mayhave a different arrangement relative to each other and the actuatablemember 1049.

Many of the embodiments disclosed herein make use of a shape memorymaterial (SMM), such as nitinol, shape memory polymers, and the like, asa control in an adjustable fluid resistor. As noted previously, suchfluid resistors allow controlled flow of aqueous from within theanterior chamber of the eye to a location into which the aqueous candefuse. One such location is within or on top of the sclera posterior tothe cornea. In general, SMM elements utilized in the various devicesdisclosed herein can be repeatedly activated in one direction toincrease fluid resistance and in another direction to decrease fluidresistance. In some embodiments, for example, each of multipleactivations on targets in one section of the actuation element willincrementally increase the resistance, while multiple activations ontargets in another section of the actuation element will incrementallydecrease the resistance. When a target is heated above its transitiontemperature, such as by heating via non-invasive laser energy, the SMMshifts from its larger volume, lower stiffness, low temperaturemartensite (Mar) form to its high temperature, smaller volume, stifferaustenite form (Aus).

-   -   Aus (austenite) 75-83 GPa, smaller volume, high temperature    -   Mar (martensite) 28-40 GPa, larger volume, low temperature

One such configuration is illustrated in FIGS. 11A-11C, which representsa side view of a ribbon or wire configured in accordance withembodiments of the present technology. Referring first to FIG. 11A, theribbon has been shape-set in a form comprising multiple uniform folds.As illustrated, there are six folds, but it will be appreciated that inother embodiments ribbons with more or less folds can be used dependingon the desired amount of resolution and displacement. Referring next toFIG. 11B, the ribbon can then be mounted between two anchors such thatthe constrained length is larger than the heat set length. Referring nowto FIG. 11C, applying heat to the fold(s) in the portion of SMM heatedabove its Aus, shifts it from its less stiff, higher volume Mar form toits stiffer and lower volume Aus form. In the illustrated embodiment,the entire SMM component is not allowed to return to its heat set shapeeven if the entire portion of SMM is heated above the transformationtemperature. The unheated portion can expand further to compensate. Inaddition, heating previously unheated sections is expected to stretchpreviously unheated and heated sections reversing the mechanism.

FIGS. 12A and 12B illustrate a fluid control element 1201 configured inaccordance with another embodiment of the present disclosure. The fluidcontrol element 1201 may be used with any of the variable flow shuntsdescribed herein or other suitable shunts. In this embodiment, the fluidcontrol element 1201 comprises variable fluid resistors actuated by SMMelements (like those described above with reference to FIGS. 11A-11C).Referring first to FIG. 12A, fluid control element 1201 comprises a base1211 and a flow-through drainage tube 1212 carried by and operablycoupled to the base 121. For example, the flow-through tube 1212 can befixed to the base 1211 via flow-through anchors 1209. In otherembodiments, however, other suitable techniques may be used to securethe flow-through tube 1212 to the base 1211. The flow-through tube 1212is also operably engaged with an actuator 1218. In the illustratedembodiment, the actuator 1218 comprises a ribbon or wire composed of SMMand including a plurality of folds. The actuator 1218 has a fixed lengthand each end of the actuator 1218 is anchored to the base 1211.

The actuator 1218 may be actuated using techniques similar to thosedescribed above with reference to FIGS. 11A-11C. During operation, forexample, the tops of the folds along the actuator 518 may be used astarget regions to be selectively heated via non-invasive energy (e.g.,laser energy) to locally heat such regions along the actuator 518. Asdiscussed previously with respect to FIGS. 11A-11C, heating folds on oneside relative to the other side will allow incremental shifting ofresistance (up or down) to modify the state of the actuator 1218, andthereby change fluid resistance through the flow-through tube 1212. FIG.12A, for example, illustrates a low-resistance state of the fluidcontrol element 1201 in which the actuator 1218 is fairly uniform alongits length and provides minimal resistance or interference with fluidflow through the flow-through tube 1212. FIG. 12B illustrates a highresistance state of the of the fluid control element 1201. The highresistance state or high resistance position is a result, for example,of multiple actuations via the actuation element 1218 to theflow-through tube 1212. In particular, heating each of the folds of theactuation element 1218 on the left side of the flow-through tube 1212above the actuation temperature causes the actuation element 1218 inthis region to shrink, thereby “pinching” and compressing theflow-through tube 1212 in this direction and increasing fluid resistancetherethrough. When desired, fluid control element 1201 can betransformed again to additional resistance positions or orientationsthan that shown in FIG. 12B (e.g., back to the state shown in FIG. 12Aor a different state) via further manipulation/modulation (e.g., heatingselected regions) of actuation element 1218.

FIGS. 13A and 13B are partially schematic, cross-sectional views of avariable fluid resistor comprising a dual lumen elastomeric tube 1312configured in accordance with still another embodiment of the presenttechnology. More specifically, FIG. 13A illustrates the elastomeric tube1312 in an initial or low-resistance state before modulation. Theelastomeric tube 1312 comprises a first lumen or a fluid flow-throughlumen 1316 having an initial cross-sectional shape (e.g., a “D” shapedlumen). The elastomeric tube 1312 further comprises a second lumen or acontrol lumen 1336 adjacent the first lumen 1316 and a diaphragmtherebetween. The control lumen 1336 contains one or more actuationelements 1318. In the illustrated embodiment, for example, the actuationelement 1318 is composed of SMM and includes a first or expansionportion 1314 and a second or shrinkage portion 1315. Although only asingle actuation element 1318 is shown in the cross-sectional views ofFIGS. 13A and 13B, it will be appreciated that in further embodimentsmultiple actuation elements 618 can be arrayed serially along a lengthof the elastomeric tube 1312.

FIG. 13B illustrates the elastomeric tube 1312 in an increased or higherresistance state after activation of the actuation element 1318. Morespecifically, non-invasive energy (e.g., heating via laser energy) hasbeen used on expansion portion 1314 of the actuation element 1318,thereby causing the actuation element 1318 to expand. Such expansionpushes the diaphragm toward the flow-through lumen 1316 and decreasesthe cross-sectional dimension of the flow-through lumen 1316. Thisdecrease in size of the flow-through lumen 1316 accordingly increasesthe fluid resistance through the lumen 1316. The cross-sectionaldimension of the flow-through lumen 1316 can be further modified viaadditional modulation of the actuation element 1318. For example, fluidresistance through the flow-through lumen 1316 can be further decreasedby additional heating of the expansion portion 1314 or returned to alower resistance state via heating of the shrinkage portion 1315.

In some FIG. 13C illustrates another embodiment of an inflow mountedvariable resistor 1320 in accordance with the present technology. Inthis embodiment, multiple actuation elements 618 can be arrayed seriallyalong a length of control lumen 636 (FIG. 13A). As the expansion portion1314 of each target actuation element 1318 is actuated, the length ofthe restricted area is increased thereby increasing the fluid resistancelinearly. Likewise, actuating shrinkage portion(s) 1315 of targetactuation element(s) 1318 can decease fluid resistance. As shown in FIG.13C, such fluid controls can be incorporated into a shunt plate 1303,inflow tube 1305, an outflow mounted variable resistor 1321, and/or theoutflow tube (not shown).

FIG. 13D illustrates a variable fluid resistor configured in accordancewith still another embodiment of the present technology. The embodimentshown in FIG. 13D can include a number of features similar to those ofthe variable fluid resistors described above with reference to FIGS. 13Aand 13B. In this embodiment, however, the elastomeric tube 1312comprises a single fluid flow-through lumen 1316, while an actuationassembly 1322 positioned along the elastomeric tube 1312 comprises adual-lumen arrangement similar to that described above. In particular,the actuation assembly 1322 comprises a first lumen 1316′ having apredetermined cross-sectional shape (e.g., a “D” shaped lumen). Theelastomeric tube 1312 is positioned within and extends through the firstlumen 1316′ of the actuation assembly 1322. The actuation assembly 1322further comprises a second lumen or a control lumen 1336′ adjacent thefirst lumen 1316′. The control lumen 1336′ contains one or moreactuation elements 1318 similar to the actuation elements describedpreviously. In this embodiment, for example, the actuation element 1318is composed of SMM and includes a first or expansion portion 1314 and asecond or shrinkage portion 1315.

Selectively heating the expansion portion 1314 can cause the actuationelement 1318 to expand. Like the arrangement described above withreference to FIGS. 13A and 13B, such expansion decreases thecross-sectional dimension of the elastomeric tube 1312 by driving theelastomeric tube 1312 away from the control lumen 1336′ and toward fixedinner walls of the first lumen 1316′. By decreasing the cross-sectionaldimension of the elastomeric tube 1312, fluid resistance through thetube 1312 is accordingly increased. The fluid resistance throughelastomeric tube 1312 can be further decreased by additional heating ofthe expansion portion 1314, or the elastomeric tube 1312 can be returnedto a lower resistance state via heating of the shrinkage portion 1315 ofactuation element 1318. Although only a single actuation assembly 1322is shown, it will be appreciated that in further embodiments multipleactuation assemblies 1322 can be positioned along a length ofelastomeric tube 1312.

FIGS. 13E and 13F are partially schematic, cross-sectional views of afluid resistor comprising a dual lumen elastomeric tube 1312′ configuredin accordance with yet another embodiment of the present technology. Thefluid resistor in the embodiment illustrated in FIGS. 13E and 13Foperates using a similar principle to that described above withreference to FIGS. 13A and 13B. For example, FIG. 13E illustrates theelastomeric tube 1312′ in an initial or low-resistance state beforemodulation. The elastomeric tube 1312′ comprises a first lumen or afluid flow-through lumen 1316′ having an initial cross-sectional shape(e.g., a “D” shaped lumen). The elastomeric tube 1312′ further comprisesa second lumen or a control lumen 1336′ adjacent the first lumen 1316.The control lumen 1336′ is filled with a control fluid. Referring nextto FIG. 13F, when a volume of control fluid is increased, thecross-sectional dimension of the flow-through lumen 1316 is decreased asan elastomeric diaphragm 1337 expands into the flow-through lumen 1316′,thereby increasing fluid resistance and decreasing flow through thelumen 1316′. Likewise, when control fluid is removed from the controllumen 1336′, the elastomeric diaphragm 1337 retracts and thecross-sectional dimension of the flow-through channel 1316′ isincreased, thereby reducing fluid resistance and increasing outflowthrough the lumen 1316′. Control fluid can be removed or added to thecontrol lumen 1336′, for example, using a syringe. In some embodiments,one or more reservoirs (not shown) may be fluidly interfaced with thecontrol lumen 1336′ and fluid volume of the control lumen 1336′ can beadjusted by adding or removing fluid from the reservoir(s). Further, itwill be appreciated that in some embodiments fluid control systemsconfigured in accordance with the present technology may comprisemultiple fluid control sealed lumens serially distributed along thelength of the control system.

FIGS. 14A and 14B illustrate yet another embodiment of a SMM-basedactuator 1418 configured in accordance with the present technology andadapted for use in an adjustable flow glaucoma shunt. In thisembodiment, the actuator 1418 comprises one or more coils 1424 arrangedabout a periphery of clamping arm 1423. The coil(s) 1424 and clampingarm 1423 may both be composed of SMM. Anchors 1410 are positioned tofixedly hold the actuator 1418 in position on base 1411 such that theclamping arm 1423 is pressed against elastomeric flow-through tube 1412.The elastomeric flow-through tube 1412 can have a stiffness thatmaintains the outer coils 1424 in a state comparable to the mountedstate for the ribbon/wire actuators 1318 described above with referenceto FIGS. 12A-13B.

In operation, sections of the coil(s) 1424 can be selectively actuatedto adjust the clamping pressure of the clamping arm 1423 againstflow-through tube 1412, and thereby the fluid resistance. Referring toFIG. 14B, for example, coils 1424 on one side (e.g., the right side) ofclamping arm 1423 can be heated via laser energy applied at target site1413. Such heating actuates the selected coils 1424 and causes them tocoil more tightly, thereby actuating the clamping arm 1423 to increasepressure and increase resistance on the flow-through tube 1412.Actuation of the coils 1424 on the other side of the clamping arm 1423(the left side coils) relaxes the clamping arm 1423 and therebydecreases pressure and resistance on the flow-through tube 1412.

In alternate embodiments, the actuator 1418 can be set in a rest orinitial position such that the clamping arm 1423 completely occludes theflow-through 1412 and the coils 1424 can be selectively adjusted toincrease or decrease the tension of the clamping arm 1423 against thebase 1411. The base 1411 accordingly acts as an anvil as the clampingarm 1423 drives the flow-through tube 1412 against it during operation.In some embodiments, such an arrangement may be used to operate anadjustable opening pressure valve (not shown), which is set toselectively control the desired control Intraocular Pressure (IOP). Inother embodiments, however, the actuator 1418 may have a differentarrangement and/or include different features.

FIGS. 15A-15C illustrate an adjustable glaucoma shunt 1500 configured inaccordance with another embodiment of the present technology and includefluid resistor elements such as those described above with reference toFIGS. 14A and 14B. FIG. 15A, for example, is an exploded view of theshunt 1500, and FIG. 15B is a top view of the assembled shunt 800.Referring to FIGS. 15A and 15B together, the shunt 1500 comprises anelastomeric flow-through tube 1512 carried by and operably coupled withcontrol assembly 1519. The flow-through tube 1512 comprises an inflowregion or inflow portion 1505 at one end of the flow-through tube 1512,and an outflow assembly 1527 including one or more outflow ports 1502 ator near an opposite end of the flow-through tube 1512.

The shunt 1500 also includes an actuator 1518 carried by and operablycoupled to control assembly 1519. The actuator 1518 can be similar tothe actuator 1418 described above with reference to FIGS. 14A and 14B.In the illustrated embodiment, for example, actuator 1518 includes aclamping arm 1523 operably coupled to and positioned between a pluralityof coils 1524. The coils 1524 (like the coils 1424 described above) canbe composed of SMM and adapted to selectively modulate the flow-throughtube 1512 to increase/decrease pressure therethrough as describedpreviously.

In the illustrated embodiment, the shunt 1500 includes a pressure port1528 and corresponding pressure transducer 1529 configured to bepositioned within a pressure transducer housing 1530 on the controlassembly 1519. The pressure port 1528/pressure transducer 1529 areconfigured to provide pressure information to a clinician/operatorduring operation of the shunt 1500. In other embodiments, the pressureport and/or pressure transducer 1529 may have a different arrangementrelative to each other and the other components of the shunt 1500.Further, the pressure port 1528/pressure transducer 1529 are optionalcomponents that may not be included in some embodiments. In someembodiments, the shunt 1500 may also optionally include a differentialport 1526 in the control assembly 1519.

The shunt 1500 can further include a plate 1503 configured to bepositioned over at least a portion of the control assembly 1518,flow-through tube 1512, and actuator 1518. The plate 1503 can include awindow 1531 such that when the shunt 1500 is assembled (as shown in FIG.15B), the window 1531 provides access to the actuator 1518 and othercomponents carried by the control assembly 1519.

FIG. 15C illustrates an implant tool 1534 configured to deliver andposition shunt 1500 within an eye capsule of a patient (not shown) inaccordance with an embodiment of the present technology. The implanttool 1534 can include, for example, a guide needle 1532 configured tocarry the shunt 1500 for delivery, and a guide needle release 1533 thatan operator can actuate to release the shunt 1500 once at a desiredposition/orientation within the patient. In other embodiments, however,the implant tool 1534 may have a different configuration and/or theshunt 1500 may be delivered using other suitable devices/techniques.

FIGS. 16A-16E illustrate various features of an adjustable glaucomashunt 1600 configured in accordance with yet another embodiment of thepresent technology. The shunt 1600 can include a number of featuressimilar to the shunt 1500 described above with reference to FIGS.15A-15C. For example, as best seen in FIG. 16A, the shunt 1600 comprisesa flow-through tube 1612 having an inflow port or inflow region 1601 atone end, and an outflow port 1602 at an opposite end of the flow-throughtube 1612. The shunt 1600 further comprises a control assembly 1619configured to modulate flow through the flow-through tube 1612. Theflow-through tube 1612, control assembly 1619, and a number of othercomponents of the shunt are carried by plate 1603.

The shunt 1600 differs from the shunt 1500, however, in that the shunt1600 includes a different system for modulating fluid flow along theflow-through tube 1612. In particular, rather than the actuator 1518including the clamping arm 1523/coils 1524 described previously, theshunt 1600 in the present embodiment comprises an arrangement similar tothat described above with reference to FIGS. 13E and 13F. Referring toFIGS. 16B-16D, for example, the control assembly 1629 of shunt 1600comprises a control fluid 1644 contained within a control fluid chamber1636 comprising an annular region around a thin walled tubularflow-through channel of tube 1612. The control fluid chamber 1636 isfluidly isolated from the flow-through channel. A reservoir 1643 isinterfaced with and in fluid communication with the control fluidchamber. The reservoir 1643 is configured to provide a larger target forconveniently injecting or removing control fluid 1636 from the system.In operation, control fluid 1644 may be added/removed from the controlfluid chamber 1636 to increase/decrease a fluid cross-sectionaldimension of an aqueous flow path 1616 through flow-through channel1612, thereby decreasing/increasing the corresponding fluid flowtherethrough.

In some embodiments, a solid core may optionally be introduced into flowpath 1616 to initially reduce the fluid cross-sectional dimension evenfurther and thereby make the flow path more sensitive to small changesin the diameter of flow-through channel 1612. In FIG. 16E, for example,optional solid core pin or element 1637 has been introduced into theflow-through channel 1612 and flow path 1616 now has an annularcross-sectional profile.

In the illustrated embodiment, the shunt 1600 further comprises apressure transducer 1629. The pressure transducer 1629 is an optionalcomponent that may not be included in some embodiments. Further, it willbe appreciated that shunt 1600 may include features other than thosedescribed herein and/or the features of shunt 1600 may have a differentarrangement relative to each other.

In many of the embodiments described herein, the actuators or fluidresistors are configured to compress or “pinch” the drainage tube duringoperation. In this way, the actuators/fluid resistors can incrementallyor continuously change the flow resistance through the drainage tube toselectively regulate pressure/flow. The actuators and fluid resistorsconfigured in accordance with the present technology can accordinglyadjust the level of resistance or compression between a number ofdifferent positions, and accommodate a multitude of variables (e.g.,IOP, aqueous production rate, native aqueous outflow resistance, and/ornative aqueous outflow rate) to precisely regulate flow rate through thedrainage tube.

The disclosed actuators and fluid resistors can all be operated usingnon-invasive energy. This feature allows such devices to be implanted inthe patient and then modified/adjusted over time without furtherinvasive surgeries or procedures for the patient. Further, because thedevices disclosed herein may be actuated via non-invasive energy, suchdevices do not require any additional power to maintain a desiredorientation or position. Rather, the actuators/fluid resistors disclosedherein can maintain a desired position/orientation without power. Thiscan significantly increase the usable lifetime of such devices andenable such devices to be effective long after the initial implantationprocedure.

EXAMPLES

Several aspects of the present technology are set forth in the followingexamples.

1. An adjustable flow shunt for treating glaucoma in a human patient,the shunt comprising:

-   -   an elongated outflow drainage tube having a proximal inflow        region and a distal outflow region; and    -   an inflow control assembly at the proximal inflow region,        wherein the inflow control assembly comprises—        -   a control element sized and shaped to slidably engage the            proximal inflow region; and        -   a spring element operably coupled between the control            element and an anchor element engaged with the proximal            inflow region;    -   wherein the proximal inflow region comprises one or more        apertures defining a fluid inlet area positioned to allow fluid        to flow therethrough and into the outflow drainage tube,    -   wherein the spring element is configured to be activated by a        non-invasive energy and, upon activation, slidably actuate the        control element along the proximal inflow region such that (a)        the one or more apertures are accessible and have a first fluid        flow cross-section or (b) the one or more apertures are at least        partially covered by the control element and have a second        fluid-flow cross-section less than the first fluid flow        cross-section.

2. The adjustable flow shunt of example 1 wherein the proximal inflowregion comprises a core element operably coupled to and extending from aproximal end of the outflow drainage tube, and wherein the one or moreapertures extend through a sidewall of the core element to define thefluid inlet area.

3. The adjustable flow shunt of example 2 wherein the core element iscomposed of a different material than the outflow drainage tube.

4. The adjustable flow shunt of example 2 wherein the core element iscomposed of a first material having a first rigidity, and wherein theoutflow drainage tube is composed of a second material having a secondrigidity less than the first rigidity.

5. The adjustable flow shunt of example 2 wherein the core element iscomposed of polyether ether ketone (PEEK), acrylic, polycarbonate,metal, ceramic, quartz, and/or sapphire.

6. The adjustable flow shunt of any one of examples 1-5 wherein theelongated outflow drainage tube is composed of silicone and/or urethane.

7. The adjustable flow shunt of any one of examples 1-6 wherein thespring element is composed of a shape memory material.

8. The adjustable flow shunt of any one of examples 1-6 wherein thespring element is composed of nitinol.

9. The adjustable flow shunt of any one of examples 1-8 wherein theinflow control assembly is configured for placement within an anteriorchamber in a region outside of the optical field of view of the eye.

10. The adjustable flow shunt of example 9 wherein the outflow drainagetube is sized and shaped to traverse a region between the anteriorchamber to a region in a suprachoroidal location of the eye.

11. The adjustable flow shunt of example 9 wherein the outflow drainagetube is sized and shaped to traverse a region between the anteriorchamber to a region in a subconjunctival location of the eye.

12. The adjustable flow shunt of any one of examples 1-11 wherein theone or more apertures comprises a single elongated slot extendingaxially along the proximal inflow region.

13. The adjustable flow shunt of any one of examples 1-11 wherein theone or more apertures comprises a plurality of apertures extendingradially about the proximal inflow region.

14. The adjustable flow shunt of any one of examples 1-11 wherein theone or more apertures comprises a plurality of apertures extendinghelically about the proximal inflow region.

15. The adjustable flow shunt of any one of examples 1-14 wherein thespring element is configured to be activated via laser energy.

16. The adjustable flow shunt of any one of examples 1-15 wherein thespring element comprises a first spring and the anchor comprises a firstanchor, and wherein the first spring and first anchor are positioned ona first side of the control element, and wherein the inflow controlassembly further comprises:

-   -   a second spring and a corresponding second anchor on a second,        opposite side of the control element;    -   wherein the first and second spring elements are configured to        be selectivity activated by non-invasive energy and, upon        activation, slidably move the control element along the proximal        inflow region in a first direction or a second direction,        respectively, such that (a) the one or more apertures have the        first fluid flow cross-section, or (b) the one or more apertures        are at least partially covered by the control element and have        the second fluid-flow cross-section less than the first fluid        flow cross-section.

17. The adjustable flow shunt of example 16 wherein the first and secondspring elements are configured such that, upon activation, the controlelement slidably moves the control element along the proximal inflowregion such that the one or more apertures are fully covered andinaccessible.

18. The adjustable flow shunt of any one of examples 1-15 wherein thespring element and corresponding anchor element are positioned on aproximal end of the control element between the control element and theoutflow drainage tube.

19. The adjustable flow shunt of any one of examples 1-15 wherein thespring element comprises one or more coil springs extending about theproximal inflow region.

20. The adjustable flow shunt of any one of examples 1-15 wherein thespring element comprises one or more elongated bow springs extendingbetween the control element and the anchor element.

21. An adjustable flow shunt assembly for treatment of glaucoma, theshunt assembly comprising:

-   -   an elongated drainage tube having a proximal portion and a        distal portion, wherein the proximal portion includes an inflow        port configured to be in fluid communication with a fluid        chamber in an eye of the patient;    -   a variable resistor assembly configured to selectively control        flow of fluid into the inflow port, wherein the variable        resistor assembly comprises—        -   a base portion;        -   an aperture plate carried by the base portion, wherein the            aperture plate comprises a plurality of first apertures            extending therethrough;        -   a standoff plate carried by and extending away from the            aperture plate, wherein the standoff plate comprises a            plurality of second apertures extending therethrough, and            wherein the second apertures are aligned with corresponding            first apertures of the aperture plate; and        -   a membrane disposed on a carried by the standoff plate,            wherein the membrane is positioned to sealably cover an open            end of each of the second apertures;    -   wherein, during operation, a portion of the membrane over one or        more second apertures of the standoff plate is configured to be        selectively targeted and removed via non-invasive energy,        thereby creating a fluid path from the site of fluid in the        patient through the accessible open ends of the targeted second        apertures, the corresponding first apertures, and into the        drainage tube.

22. The adjustable flow shunt assembly of example 21 wherein:

-   -   the first apertures have a first cross-sectional dimension; and    -   the second apertures have a second cross-sectional dimension        greater than the first cross-sectional dimension.

23. The adjustable flow shunt assembly of example 21 wherein the firstapertures have identical cross-sectional dimensions.

24. The adjustable flow shunt assembly of any one of examples 21-23wherein the standoff plate is composed, at least in part, of ahydrophobic material configured to be at least partially melted vianon-invasive energy.

25. The adjustable flow shunt assembly of any one of examples 21-23wherein the standoff plate is composed, at least in part, of a waxmaterial configured to be at least partially melted via non-invasiveenergy.

26. The adjustable flow shunt assembly of any one of examples 21-23wherein the base portion, aperture plate, and standoff plate of thevariable resistor assembly are separate, discrete components operablycoupled together.

27. The adjustable flow shunt assembly of any one of examples 21-23wherein the standoff plate and membrane are fabricated as a single,unitary component composed of the same material.

28. The adjustable flow shunt assembly of any one of examples 21-23wherein the aperture plate and standoff plate are fabricated as asingle, unitary component composed of the same material.

29. The adjustable flow shunt assembly of any one of examples 21-28wherein:

-   -   the membrane further comprises a plurality of target indicia        aligned with and corresponding with individual second apertures;        and    -   during operation, the non-invasive energy is delivered to        corresponding target indicia of the membrane to selectively        remove membrane material at the targeted location.

30. An adjustable flow shunt for treatment of glaucoma in a humanpatient, the adjustable flow shunt comprising:

-   -   an elongated outflow tube having (a) a proximal inflow portion        configured for placement within an anterior chamber in a region        outside of an optical field of view of an eye of the patient,        and (b) a distal outflow portion at a different location of the        eye; and    -   an actuator positioned along the outflow tube between the inflow        portion and the outflow portion, wherein the actuator is        transformable between an open position that allows fluid to flow        through the outflow tube and resistance positions that partially        obstruct fluid flow through the outflow tube,    -   wherein during operation, the actuator is movable between        positions in response to non-invasive energy.

31. The adjustable flow shunt of example 30 wherein the actuator isconfigured to partially obstruct fluid flow through the outflow tube inthe resistance positions by engaging the outflow tube and changing adiameter and/or a cross-sectional shape of the outflow tube.

32. The adjustable flow shunt of example 30 or example 31 wherein theactuator is movable between positions in response to laser energy.

33. The adjustable flow shunt of example 30 wherein:

-   -   the outflow tube comprises a dual lumen tube having a first        lumen for carrying fluid therethrough and a second lumen        adjacent to the first lumen and separated by the first lumen by        a diaphragm;    -   the actuator is positioned within the second lumen, and wherein        the actuator comprises one or more actuation elements configured        to transform between and expanded state and an initial state in        response to the non-invasive energy,    -   in the expanded state, actuation elements engage and push the        diaphragm toward the first lumen and decrease a cross-sectional        dimension thereof.

34. The adjustable flow shunt of any one of examples 30-33 wherein theactuator is configured to hold the open position or one of theresistance positions without power.

35. An adjustable flow shunt, comprising:

-   -   an elongated outflow tube having a proximal inflow portion        configured for placement at a first location within an eye of        the patient, and a distal outflow portion at a second location        of the eye spaced apart from the first location,    -   wherein the outflow tube comprises a dual lumen tube having a        first lumen for carrying fluid therethrough and a second lumen        adjacent to the first lumen and fluidly isolated from the first        lumen; and    -   a control fluid disposed within the second lumen,    -   and wherein, during operation—        -   increasing a volume of control fluid within the second lumen            decreases a cross-sectional dimension of the first lumen,            thereby partially obstructing fluid flow through the first            lumen, and        -   decreasing a volume of control fluid within the second lumen            increases a cross-sectional dimension of the first lumen,            thereby increasing fluid flow through the first lumen.

36. The adjustable flow shunt of example 35 wherein the elongatedoutflow tube comprises an elastomeric tube.

37. The adjustable flow shunt of example 35 or example 36, furthercomprising a reservoir in fluid communication with the second lumen, andwherein the volume of control fluid within the second lumen is changedby transferring control fluid to and/or from the reservoir.

38. The adjustable flow shunt of any one of examples 35-37 wherein thevolume of control fluid within the second lumen is changed bytransferring control fluid to and/or from the second lumen via asyringe.

39. The adjustable flow shunt of any one of examples 35-38 wherein thefirst lumen is separated from the second lumen by a diaphragm, andwherein:

-   -   increasing a volume of control fluid within the second lumen        moves the diaphragm toward the first lumen and decreases a        cross-sectional dimension thereof, and    -   decreasing a volume of control fluid within the second lumen        moves the diaphragm away from the first lumen and increases a        cross-sectional dimension thereof.

40. A shunt for treatment of glaucoma in a human patient, the shuntcomprising:

-   -   an elongated outflow drainage tube having a proximal inflow        region and a distal outflow region;    -   an inflow control assembly at the proximal inflow region; and    -   a transition region along the outflow tube between the inflow        region and the outflow region, wherein, during operation, the        transition region is transformable between a first generally        linear delivery shape and a second shape different than the        first shape to anchor the shunt at a desired location of the        eye.

41. The shunt of example 40 wherein the outflow drainage tube isconfigured to be delivered via guidewire, and wherein the transitionregion is configured to transform between the first delivery shape andthe second shape upon removal of the guidewire.

42. The shunt of example 40 or example 41 wherein the transition regionis configured to transform between the first delivery shape and thesecond shape upon application of non-invasive energy to one or moreselected areas of the transition region.

43. The shunt of example 40 or example 41 wherein the transition regionis configured to transform between the first delivery shape and thesecond shape in response to application of non-invasive laser energy toone or more selected areas of the transition region.

44. The shunt of any one of examples 40-43 wherein the second shapecomprises a generally “L” shaped configuration.

CONCLUSION

The above detailed description of embodiments of the technology are notintended to be exhaustive or to limit the technology to the precise formdisclosed above. Although specific embodiments of, and examples for, thetechnology are described above for illustrative purposes, variousequivalent modifications are possible within the scope of the technologyas those skilled in the relevant art will recognize. For example, any ofthe features of the variable flow shunts described herein may becombined with any of the features of the other variable flow shuntsdescribed herein and vice versa. Moreover, although steps are presentedin a given order, alternative embodiments may perform steps in adifferent order. The various embodiments described herein may also becombined to provide further embodiments.

From the foregoing, it will be appreciated that specific embodiments ofthe technology have been described herein for purposes of illustration,but well-known structures and functions associated with variable flowshunts have not been shown or described in detail to avoid unnecessarilyobscuring the description of the embodiments of the technology. Wherethe context permits, singular or plural terms may also include theplural or singular term, respectively.

Moreover, unless the word “or” is expressly limited to mean only asingle item exclusive from the other items in reference to a list of twoor more items, then the use of “or” in such a list is to be interpretedas including (a) any single item in the list, (b) all of the items inthe list, or (c) any combination of the items in the list. Additionally,the term “comprising” is used throughout to mean including at least therecited feature(s) such that any greater number of the same featureand/or additional types of other features are not precluded. It willalso be appreciated that specific embodiments have been described hereinfor purposes of illustration, but that various modifications may be madewithout deviating from the technology. Further, while advantagesassociated with some embodiments of the technology have been describedin the context of those embodiments, other embodiments may also exhibitsuch advantages, and not all embodiments need necessarily exhibit suchadvantages to fall within the scope of the technology. Accordingly, thedisclosure and associated technology can encompass other embodiments notexpressly shown or described herein.

1-22. (canceled)
 23. An adjustable flow shunt for treating a humanpatient, the shunt comprising: an elongated drainage element having alumen extending at least partially therethrough and an opening in fluidcommunication with the lumen; a control element configured to interfacewith the opening; and a shape memory actuation element operably coupledto the control element, wherein the shape memory actuation element isconfigured to be selectively activated by non-invasive energy and, uponactivation, move the control element to (a) increase an area of theopening available for fluid flow, or (b) decrease the area of theopening available for fluid flow.
 24. The shunt of claim 23 wherein thecontrol element and the shape memory actuation element form a unitarystructure.
 25. The shunt of claim 24 wherein the unitary structure is atleast partially composed of nitinol.
 26. The shunt of claim 23 whereinthe shape memory actuation element is configured to slidably move thecontrol element relative to the elongated drainage element.
 27. Theshunt of claim 23 wherein the shape memory actuation element isconfigured to undergo a geometric change upon activation by thenon-invasive energy.
 28. The shunt of claim 23 wherein the shape memoryactuation element is configured to transition from a martensitic stateto a shape memory state upon activation by the non-invasive energy. 29.The shunt of claim 23 wherein the shape memory actuation element is afirst shape memory actuation element and is configured, upon activation,to move the control element to increase the area of the openingavailable for fluid flow, and wherein the shunt further comprises: asecond shape memory actuation element, wherein the second shape memoryactuation element is configured to be selectively activated bynon-invasive energy and, upon activation, move the control element todecrease the area of the opening available for fluid flow.
 30. The shuntof claim 29 wherein the first shape memory actuation element is operablycoupled to the second shape memory actuation element such that:activation of the first shape memory actuation element changes ageometry of the second shape memory actuation element, and activation ofthe second shape memory actuation element changes a geometry of thefirst shape memory actuation element.
 31. The shunt of claim 23 whereinthe shunt is configured to be implanted in an eye of the human patient.32. An adjustable flow shunt for treating a human patient, the shuntcomprising: an elongated drainage element having a lumen extending atleast partially therethrough; a control element configured to at leastpartially control a flow of fluid through the lumen; and a shape memoryactuation element operably coupled to the control element, wherein theshape memory actuation element is configured to be selectively activatedby non-invasive energy and, upon activation, move the control elementrelative to the elongated drainage element to change the fluidresistance through the lumen.
 33. The shunt of claim 32 wherein thecontrol element and the shape memory actuation element form a unitarystructure.
 34. The shunt of claim 33 wherein the unitary structure is atleast partially composed of nitinol.
 35. The shunt of claim 32 whereinthe shape memory actuation element is configured to slidably move thecontrol element relative to the elongated drainage element.
 36. Theshunt of claim 32 wherein the shape memory actuation element isconfigured to undergo a geometric change upon activation by thenon-invasive energy.
 37. The shunt of claim 32 wherein the shape memoryactuation element is configured to transition from a martensitic stateto a shape memory state upon activation by the non-invasive energy. 38.A method of adjusting fluid flow through a shunt implanted in a humanpatient, wherein the shunt includes an elongated drainage element, acontrol element, and a shape memory actuation element, the methodcomprising: non-invasively delivering energy to the shape memoryactuation element to selectively activate the shape memory actuationelement, wherein selectively activating the shape memory actuationelement moves the control element relative to an opening of theelongated drainage element, thereby (a) increasing an area of theopening available for fluid flow, or (b) decreasing the area of theopening available for fluid flow.
 39. The method of claim 38 whereinincreasing the area of the opening available for fluid flow decreasesfluid resistance through the shunt, and wherein decreasing the area ofthe opening available for fluid flow increases fluid resistance throughthe shunt.
 40. The method of claim 38 wherein selectively activating theshape memory actuation element includes inducing a geometric change inthe shape memory actuation element, and wherein inducing the geometricchange moves the control element.
 41. The method of claim 40 whereinselectively activating the shape memory actuation element includestransitioning the shape memory actuation element from a martensiticstate to a shape memory state, and wherein transitioning the shapememory actuation element from the martensitic state to the shape memorystate induces the geometric change in the shape memory actuationelement.
 42. The method of claim 38 wherein the shunt is implanted inthe patient's eye.